MAREL Marel hf.

Marel: Q3 2022 Investor Meeting Presentation

Marel: Q3 2022 Investor Meeting Presentation

Marel hf. published its Q3 2022 Condensed Consolidated Financial Interim Statements after market closing on 2 November 2022.

Please find attached the Q3 2022 investor presentation for today’s investor meeting at 8:30 am GMT (9:30 am CET), where senior management will give an overview of the financial results and operational highlights in the third quarter.

The meeting is webcast live on and a recording is available after the meeting on .

Members of the investment community can also join the conference call by dialing:

  • IS: (PIN 84639778#)
  • NL:
  • UK: 5
  • US:

Investor relations

For further information, please contact Marel Investor Relations via email or tel. .

About Marel

Marel (NASDAQ: MAREL; AEX: MAREL) is a leading global provider of advanced food processing equipment, systems, software, and services to the poultry, meat and fish industries. In line with its 2017- 2026 growth strategy, Marel has gradually expanded its business model into adjacent industries, where most recently the acquisition of Wenger has added a fourth pillar focused on pet food, plant-based protein and aqua feed. Our united team of over 7,000 employees in over 6 continents delivered EUR 1.4 billion in revenues in 2021. Annually, Marel invests around 6% of revenues in innovation. By continuously transforming food processing, we enable our customers to increase yield and throughput, ensure food safety and improve sustainability in food production. Marel was listed on NASDAQ Iceland in 1992 and dual-listed on Euronext Amsterdam in June 2019. For further information, please visit .

Attachment



EN
03/11/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Marel hf.

Martijn Den Drijver
  • Martijn Den Drijver

MAREL HF : A solid quarter, 2024 guidance to be met, slight delay in J...

>Beats on order intake and EBIT (margin), sales a miss, ND/EBITDA down - MAREL beat css on order intake which is encouraging, also because order intake is up both QoQ and YoY (+3%). Sales of €387m missed css by 4%, primarily because of 1/ weak ad-hoc orders as order intake has been weak for a few quarters now and 2/weak sales in Poultry and Fish. Adjusted EBIT came in at €36.2m or a margin of 9.4% versus css of €33.4m or a margin of 8.3%. That is a beat of 8% on adj....

ResearchPool Subscriptions

Get the most out of your insights

Get in touch